Three more health apps obtained reimbursement in Germany

23

Jan 2023

On December 26, 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by sickness funds.

The “edupression.com®” reimbursable health app was introduced in the Directory. The “edupression.com®”, developed by SOFY GmbH, Austria, consists of the edupression.com® system, with edupression.com® psychoeducation and edupression.com® mood diagram. The system is a web-based software that can be called up and accessed from any platform using standard browsers with an Internet connection (Software-as-a-Service). The application guides the patients with dep through the program along the "Activity Feeds" and plays out multimedia information and exercises from psychodeduction for self-help daily. It also contains elements of computer-based cognitive behavioral therapy. The app is available in German and English with a tariff of €357 (first subscription) and €178.50 (renewal of the subscription).

“elona therapy depression”, developed by Elona Health GmbH, Germany, is a digital health app for outpatient psychotherapy that intelligently combines digital interventions and regular talk therapy, thus supporting the treatment of unipolar depression. Patients have access to tailored psychotherapeutic resources between therapy sessions, including interventions, activities, exercises, and psychoeducational content. The app is available in German with a tariff of €535.49.

“Kaia COPD”, developed by kaia health software GmbH, is a digital app for adult patients with chronic obstructive pulmonary disease (COPD), developed together with pulmonologists. It conveys evidence-based and guideline-compliant content of pulmonary rehabilitation to improve physical performance and health-related quality of life. “Kaia COPD” consists of the following therapy elements: movement, patient education as well as relaxation, and breathing techniques. The contents are based on the recommendations of the National COPD Care Guideline. The app is available in German and English with a tariff of €415.

The full details in German can be found here (edupression.com®), here (elona therapy depression), and here (Kaia COPD).

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

27

Jan 2023

On January 09, 2023, the National Institute for Health and Disability Insurance (INAMI-RIZIV) published 2023 tariffs for the “low variability care” (APR-DRG) system. APR-DRG logic for 2023 is not published as of January 27, so no information about its changes or new DRGs is available.

Read more

26

Jan 2023

The updated German Uniform Evaluation Standard (EBM) catalog came into force on January 1, 2023. The EBM catalog (Einheitlicher Bewertungsmaßstab) regulates the reimbursement of services in the public outpatient sector in Germany and is updated once a quarter (four times a year). Among other changes, a new code for "zanadio" health app for follow-up and evaluation was introduced in the catalog.

Read more

25

Jan 2023

On December 31, 2022, the Decree defining the reimbursement of medical telemonitoring activities via the new framework was published in the Official Journal of the French Republic. The Decree determines the methods of evaluation of digital solutions, registration for reimbursement, modification of the registration conditions, removal and invoicing of medical telemonitoring activities, as well as the conditions for setting the reimbursement packages.

Read more

24

Jan 2023

In December 2022, NHS England launched a consultation on the preliminary 2023/25 NHS Payment Scheme, which is set for two years and will replace the National Tariff Payment System from April 2023. Two new cardiovascular categories (antibacterial envelope, mitral valve repair and replacement devices) are proposed for inclusion in the 2023/24 High Cost Device List (will be updated and reissued for 2024/25). The deadline for comments submission is January 27, 2023.

Read more

20

Jan 2023

In December 2022, the National Institute for Health and Care Research (NIHR) in England released six MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned laser therapy in diabetic macular oedema, EarlyCDT Lung blood test, video-assisted thoracoscopic or open lobectomy, urethral slings for stress urinary incontinence, placental growth factor (PlGF) and sFlt-1 tests, and photobiomodulation in the management of oral mucositis. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more